Dermatologists discuss the challenges of treating hypertrophic scars and how a treatment in early trials might make post-treatment recurrence less likely. More on this new approach.
Studies have begun to examine melanocytes in patients at risk for developing melanoma with the hope of developing strategies for preventing deadly tumors. Where this knowledge may lead.
As the demand for dermatologic services continues to grow, so does the use of non-physician clinicians in dermatology. Are you currently employing mid-level providers, or do you have plans to? Please tell us in this quick poll.
Click to contact the editorial team. Click to contact the sales team.
Part of the
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
